Stuart Therapeutics Announces Successful Outcome from Type C Meeting with FDA

STUART, Fla., July 18, 2022 /PRNewswire/ -- Stuart Therapeutics, Inc. (Stuart), a clinical stage company headquartered in Stuart, Florida that is ...

Related Keywords

Florida ,United States ,Bob Baratta ,Eric Schlumpf ,Drug Administration ,Stuart Therapeutics Inc ,Prnewswire Stuart Therapeutics Inc ,Typec Guidance ,Dry Eye Disease ,Responder Rate ,Chief Medical Officer ,Collagen Mimetic Peptide ,Stuart Therapeutics ,